Clinical practice guidelines in end-stage renal disease: A strategy for implementation

Alan S. Kliger, William E. Haley

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Abstract

Clinical practice guidelines (CPGs) for end-stage renal failure (ESRD) were recently published, and represent a comprehensive review of available literature and the considered judgment of experts in ESRD. To prioritize and implement these guidelines, the evidence underlying each guideline should be ranked and the attributes of each should be defined. Strategies to improve practice patterns should be tested. Focused information for each high priority guideline should be disseminated, including a synopsis and assessment of the underlying evidence, the evidence model used to develop that guideline, and suggested strategies for CPG implementation. Clinical performance measures should be developed and used to measure current practice, and the success of changing practice patterns on clinical outcomes. Individual practitioners and dialysis facilities should be encouraged to utilize continuous quality improvement techniques to put the guidelines into effect. Local implementation should proceed at the same time as a national project to convert high priority CPGs into clinical performance measures proceeds. Patients and patient care organizations should participate in this process, and professional organizations must make a strong commitment to educate clinicians in the methodology of CPG and performance measure development and the techniques of continuous quality improvement. Health care regulators should understand that CPGs are not standards, but are statements that assist practitioners and patients in making decisions.

Original languageEnglish (US)
Pages (from-to)872-877
Number of pages6
JournalJournal of the American Society of Nephrology
Volume10
Issue number4
StatePublished - Apr 1999

ASJC Scopus subject areas

  • Nephrology

Fingerprint

Dive into the research topics of 'Clinical practice guidelines in end-stage renal disease: A strategy for implementation'. Together they form a unique fingerprint.

Cite this